Ethinyl estradiol norelgestromin

Ethinyl Estradiol Norelgestromin (Ortho Evra) Etonogestrel subdermal Implant (Implanon)... [Pg.52]

Nonoral contraceptives Ethinyl estradiol Norelgestromin Ortho Evra (transdermal patch)... [Pg.451]

Ortho Evra Ethinyl estradiol/norelgestromin Contraception Ortho-Mcneil... [Pg.794]

Patch 6 mg norelgestromin, 0.75 mg ethinyl estradiol/total patch content (Rx) Ortho Evra (Ortho-McNeil)... [Pg.198]

Switching from an oral contraceptive - Treatment with the norelgestromin/ethinyl estradiol transdermal patch should begin on the first day... [Pg.208]

Use after childbirth - Women who elect not to breast-feed should start contraceptive therapy with the norelgestromin/ethinyl estradiol transdermal patch no sooner than 4 weeks after childbirth. If a woman begins using the patch postpartum and has not yet had a period, consider the possibility of ovulation and conception occurring prior to use of the patch, and instruct her to use an additional method of contraception (eg, condoms, spermicide, diaphragm) for the first 7 days. [Pg.209]

Patch - Following application, norelgestromin and ethinyl estradiol rapidly appear in the serum, plateau by about 48 hours, and are maintained at steady state throughout the wear period. The metabolites of norelgestromin and... [Pg.213]

Patch - Results of clinical trials suggest that the norelgestromin/ethinyl estradiol transdermal patch may be less effective in women with body weight 90 kg or more (198 lbs) than in women with lower body weights. [Pg.219]

Creasy GW, Fisher AC, Hall N, Shangold GA. Transdermal contraceptive patch delivering norelgestromin and ethinyl estradiol effects on the lipid profile. J Reprod Med... [Pg.259]

Ethinylestradiol and norelgestromin patch (Evra ) Peak within 48 17 hours ethinyl estradiol and 28 hours norelgestromin... [Pg.278]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...